Cirrhosis
Cirrhosis, also known as liver cirrhosis or end-stage liver disease, is a severe liver condition characterized by the gradual replacement of healthy liver tissue with scar tissue due to chronic liver damage, leading to impaired liver function and a range of symptoms that can progress to serious complications. Early signs include tiredness, loss of appetite, and abdominal discomfort, while advanced stages may involve jaundice, fluid build-up, and life-threatening conditions such as hepatic encephalopathy and liver cancer.
Health Outcomes
- Absence of Microbial Translocation
- Alleviated Liver Injury
- Alleviated Organ Injury
- Altered Amino Acid Metabolism
- Altered Bile Acid Composition
- Altered Blood Parameters
- Altered Plasma Metabolite Levels
- Attenuated Hepatic Disorders
- Changed Albumin Level
- Changed Magnesium Level
- Changes in Liver Fibrosis Markers
- Delayed Onset of Thrombocytopenia
- Elevated Acetic Acid Levels
- Elevated Alkaline Phosphatase Levels
- Elevated Bile Acid Levels
- Elevated Hepatic Enzyme Levels
- Elevated Lactate Levels
- Elevated Serum Alanine Aminotransferase Levels
- Elevated Serum Aspartate Aminotransferase Levels
- Elevated Serum Enzyme Levels
- Enhanced Active Metabolite Levels
- Enhanced Alkaline Phosphatase Activity
- Enhanced Antioxidant Metabolism
- Enhanced Bile Salt Resistance
- Enhanced Liver Protection
- Enhanced Viability in Bile Conditions
- Improved Alcohol Metabolism
- Improved Alcohol-Associated Liver Disease Parameters
- Improved Alcohol-induced Liver Injury
- Improved CST Status to CST I
- Improved Child-Pugh Score
- Improved Child-Pugh Scores
- Improved Chronic Alcohol-Induced Liver Injury
- Improved Clearance Efficiency
- Improved Detoxification
- Improved Enzyme Levels (ADH, ALDH)
- Improved Fibrosis
- Improved Glutathione Level
- Improved Glutathione Redox Ratio
- Improved Hepatic Damage
- Improved Hepatic Disease
- Improved Hepatic Function
- Improved Hepatic Oxidative Stress
- Improved Hepatopancreas Health
- Improved Liver Antioxidant Capacity
- Improved Liver Biomarkers
- Improved Liver Disease Biomarkers
- Improved Liver Enzyme Activity
- Improved Liver Enzyme Function
- Improved Liver Function
- Improved Liver Function (γ-glutamyltranspeptidase)
- Improved Liver Health
- Improved Liver Histology
- Improved Liver Metabolic Pathways
- Improved Liver Morphology
- Improved Liver Regeneration
- Improved Minimal Hepatic Encephalopathy
- Improved NAFLD
- Improved Organ Histology
- Improved Protein Synthesis in Liver
- Improved Serum Biochemistry
- Improved Serum Protein Homeostasis
- Improved Serum Protein Status
- Improved Survival Rate in Digestive Conditions
- Improved Tolerance to Bile Salts
- Improved Vaccine Efficacy
- Improvement in Alcoholic Liver Disease
- Increased ALDH Levels
- Increased Abundance of Microbial Fibrolytic Enzymes
- Increased Alcohol Dehydrogenase Levels in Liver
- Increased Alkaline Phosphatase Activity in Skin Mucus
- Increased Aspartate Aminotransferase Concentration
- Increased Aspartate Aminotransferase Level
- Increased Aspartate Transferase Level
- Increased Betaine Content
- Increased Bile Resistance
- Increased Bile Salt Tolerance
- Increased Blood Lactate Level
- Increased Branched-Chain Fatty Acids Concentration
- Increased CD14+HLA-DR+ Cell Percentage in Males
- Increased Cellular Apoptosis
- Increased Cholesterol Excretion
- Increased Circulating Bile Acid Levels
- Increased Clinically Meaningful Collagen Synthesis
- Increased Collagen Content
- Increased Collagen Synthesis
- Increased Conjugated Bile Acid Levels
- Increased Deconjugated Bile Acid Level
- Increased Enzyme Production
- Increased Fecal Excretion of Aflatoxin B1
- Increased Ferritin Level
- Increased Hepatic Antioxidant Enzyme Levels
- Increased Hepatic Glutathione Content
- Increased Histological Damage
- Increased Hydroxy Fatty Acid Level
- Increased Late-Onset Sepsis Incidence
- Increased Liver Alcohol Metabolizing Enzyme Activity
- Increased Liver Enzyme Levels
- Increased Mortality in Patients with Enterococcal Bacteremia
- Increased Organ Weights
- Increased PT/INR
- Increased Parabenzoylaminobenzoic Acid Concentration
- Increased Plasma Deconjugated Bile Acids
- Increased Plasma GLDH
- Increased Plasma Glucagon Level
- Increased Plasma Protein Levels
- Increased Plasma Total Protein
- Increased Portal Endotoxin Levels
- Increased Production of Acetate
- Increased Prolactin Level
- Increased Proteolysis
- Increased Retinol Level
- Increased Sepsis
- Increased Serum Antioxidant Enzyme Levels
- Increased Serum Antioxidant Levels
- Increased Serum Peroxidase Activity
- Increased Serum Total Bile Acid Levels
- Increased Sex Hormone-Binding Globulin Level
- Increased Survival Rate During Candidiasis
- Increased Survival Rate of Alcohol-Treated Cells
- Increased Susceptibility to Salmonella Infection
- Increased Thermoplasma Abundance
- Increased Total Bile Acid Levels
- Increased Total Bile Acids
- Increased Total Body Iron Level
- Increased Type 1 Collagen Synthesis
- Increased Unconjugated Bile Acid Levels
- Increased Vitamin B12 Level
- Liver Histopathological Damage
- Lowered Serum Levels of Liver Injury Markers
- Maintained Albumin Levels
- Maintained Normal ALT Levels
- Maintained Normal Liver Function
- Maintained Safety with Repeated Oral Exposure
- Modulated Diurnal Short-Chain Fatty Acid Production
- Modulated Liver Metabolic Pathways
- No Change in Fibrosis
- No Cytochrome P450 Induction
- No Illness or Death Despite Bacterial Translocation
- No Significant Acute Effect on Calcium Metabolism
- No Significant Change in Aflatoxin Distribution or Metabolism
- No Significant Change in Fatigue
- Normalized INR
- Potential Modulation of FGF-19 Levels
- Preserved Liver Structure
- Prevented Increase in Total Bilirubin
- Prevented Liver Fibrosis
- Prevented Liver Injury
- Prevented Liver Pathway Dysregulation
- Prevention of Alcoholic Liver Disease
- Prolonged INR
- Reduced AFB1-Induced Liver Damage
- Reduced ALT Levels
- Reduced Abnormal Increase in Bilirubin
- Reduced Acute Pancreatitis Severity
- Reduced Alanine Aminotransferase Level
- Reduced Alanine Transaminase Activity
- Reduced Alanine Transaminase Levels
- Reduced Alcohol Consumption
- Reduced Alcohol-Induced Liver Injury
- Reduced Alcohol-Induced Liver Lipid Accumulation
- Reduced Alcohol-Induced Liver Oxidative Stress
- Reduced Alpha-1-Antitrypsin Level
- Reduced Aminotransferase Level
- Reduced Ammonia Excretion
- Reduced Ammonia Levels
- Reduced Anticoagulation / Increased Warfarin Variability
- Reduced Apolipoprotein B Level
- Reduced Appetite Changes
- Reduced Aspartate Aminotransferase Levels
- Reduced Aspartate Transaminase Activity
- Reduced Bacterial Translocation
- Reduced Bile Acid Levels
- Reduced Biochemical Marker Levels
- Reduced Blood Ammonia Level
- Reduced Blood Ammonia Levels
- Reduced Butyrylcholinesterase Activity
- Reduced Chloride Level
- Reduced Cholic Acid Level
- Reduced Chronic Consumption Toxicity
- Reduced Clonorchiasis Severity
- Reduced Colonization with Multiple Organisms
- Reduced Creatinine Level
- Reduced Cumulative Mortality from Vibrio vulnificus
- Reduced Dimethyl Sulfide Level
- Reduced Drug Concentration
- Reduced Edema
- Reduced Elevated Serum Alanine Aminotransferase (ALT)
- Reduced Fasting Conjugated Bile Acids
- Reduced Fecal Secondary Bile Acid Contents
- Reduced Ferroptosis
- Reduced Fibrinogen Level
- Reduced Fibrosis Marker Levels
- Reduced Fresh Frozen Plasma Transfusion
- Reduced Fumonisin B1 Levels
- Reduced GPT Level
- Reduced Globulin Level
- Reduced Glucuronide Metabolite Level
- Reduced Glutathione Loss
- Reduced Hepatic CML Absorption
- Reduced Hepatic Damage Indices
- Reduced Hepatic Encephalopathy
- Reduced Hepatic Glycogen Levels
- Reduced Hepatic Histological Injury
- Reduced Hepatic Inflammation
- Reduced Hepatic Inflammation Markers
- Reduced Hepatic Inflammation and Oxidative Stress
- Reduced Hepatic Inflammatory Cytokines
- Reduced Hepatic Nitric Oxide Production
- Reduced Hepatic Oxidative Stress
- Reduced Hepatic Steatosis Severity
- Reduced Hepatic Stellate Cell Activation
- Reduced Hepatic Xanthine Oxidase Activity
- Reduced Hepatocellular Carcinoma Progression
- Reduced Hepatocellular Carcinoma Recurrence
- Reduced Hepatocyte Necrosis
- Reduced Hepatocyte Oxidative Stress
- Reduced Hepatotoxicity
- Reduced Hepatotoxicity from Iron Oxide Nanoparticles
- Reduced Histological Scores
- Reduced Incidence of Abnormal Increase in Alkaline Phosphatase
- Reduced Incidence of Liver Cancer
- Reduced Incidence of Pyogenic Liver Abscess
- Reduced Isoleucine Level
- Reduced Lactate Conversion
- Reduced Lathosterol to Total Cholesterol Ratio
- Reduced Levels of Toxic Amines
- Reduced Liver Biochemical Markers
- Reduced Liver Damage
- Reduced Liver Damage Indicators
- Reduced Liver Damage Markers Levels
- Reduced Liver Disease Progression
- Reduced Liver Disease Symptoms
- Reduced Liver Enzyme Activity
- Reduced Liver Fibrosis
- Reduced Liver Function
- Reduced Liver Function Indicators
- Reduced Liver Inflammation
- Reduced Liver Inflammation Fibrosis Score
- Reduced Liver Injury
- Reduced Liver Injury Indicators
- Reduced Liver Injury Marker
- Reduced Liver Lesion Severity
- Reduced Liver Oxidative Damage
- Reduced Liver Oxidative Stress Injury
- Reduced Liver Size
- Reduced Liver Stiffness
- Reduced Liver Toxicity
- Reduced Liver Weight-to-Body Weight Ratio
- Reduced Microbial Translocation to the Liver
- Reduced NASH Activity
- Reduced Non-Infectious Complication Morbidity
- Reduced Organ Damage
- Reduced Organ Failure Severity
- Reduced Organ Weight
- Reduced Pathological Changes of Liver
- Reduced Plasma Urea Level
- Reduced Platelet Counts
- Reduced Portal Vein LPS Levels
- Reduced Procollagen Type 1 N-terminal Propeptide Level
- Reduced Proinflammatory Bacteria
- Reduced Pulsatility Index
- Reduced Salmonella Translocation to Liver
- Reduced Serpin Level
- Reduced Serum Albumin Levels
- Reduced Serum Creatinine Levels
- Reduced Serum Gamma Glutamine Transaminase Levels
- Reduced Serum Haptoglobin Concentration
- Reduced Serum Transaminase Levels
- Reduced Sitosterol Level
- Reduced Thiobarbituric Acid-Reactive Substance Levels
- Reduced Thrombocytopenia
- Reduced Total Bile Acid Levels
- Reduced Total Testosterone Level
- Reduced Total Thyroxine Level
- Reduced Total Triiodothyronine
- Reduced Toxin-induced Cytotoxicity
- Reduced Triiodothyronine Level
- Reduced Urea Level
- Reduced Urinary p-Cresol Excretion
- Reduced Vitamin E Level
- Reduced Zinc Level
- Regenerated Hepatic Tissue
- Regulated Liver Glycerophospholipid Metabolism
- Regulated Liver Metabolite Levels
- Resolved Keratomalacia
- Significant Bacterial Translocation with Intraperitoneal Administration
- Significant Histopathological Changes in Liver
- Stabilized Total Bilirubin Levels
- Stable Aspartate Aminotransferase Levels
- Stable Fecal Deconjugated Bile Acid Levels
- Unchanged Total Cholesterol